Co-infections: potentially lethal and unexplored in COVID-19

Abstract

Respiratory viral infections predispose patients to co-infections and these lead to increased disease severity and mortality. Most fatalities in the 1918 influenza outbreak were due to subsequent bacterial infection, particularly with Streptococcus pneumoniae.1 Poor outcomes in the 2009 H1N1 influenza pandemic were also associated with bacterial co-infections, although few studies captured these data.2

Cited by papers we hold 12

• Pneumonias associadas à ventilação mecânica e a suscetibilidade aos antimicrobianos dos micro-organismos isolados de pacientes da unidade de terapia intensiva de um hospital público mineiro · 2022
  Not checked
• Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions · 2022
  No notice
• Fatal Co-infections with SARS-CoV-2 and Legionella pneumophila, England · 2021
  Not checked
• Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia · 2021
  No notice
• Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations · 2021
  No notice
• Acinetobacter baumannii Infections in Times of COVID-19 Pandemic · 2021
  No notice
• Respiratory Microbial Co-infection With SARS-CoV-2 · 2020
  Not checked
• Demand and supply of invasive and noninvasive ventilators at the peak of the COVID‐19 outbreak in Okinawa · 2020
  Not checked
• Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection · 2020
  No notice
• FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2 · 2020
  No notice
• The Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis · 2020
  No notice
• COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.